Search Results - "Tomiyama, Tatsuya"

ODP353 Sustained Suppression of IGF1 with AZP-3813, a Bicyclic 16-Amino Acid Peptide Antagonist of the Human Growth Hormone Receptor and a Potential New Treatment for Acromegaly by Culler, Michael, Milano, Stephane, Kurasaki, Haruaki, Tomiyama, Tatsuya, Reid, Patrick, van der Lely, Aart Jan

“…Abstract Medical treatment of acromegaly is based on either suppressing pituitary GH secretion or inhibiting GH action by preventing interaction with its…”
Get full text

THU046 Repeated Treatment With AZP-3813, A Bicyclic, 16-Amino Acid Peptide Antagonist Of The Human Growth Hormone Receptor, Induces Enhanced Suppression Of IGF1 In Beagle Dogs by Ravel, Guillaume, Chalmey, Clémentine, Berardet, Corentin, Duracher, David, Kurasaki, Haruaki, Tomiyama, Tatsuya, Reid, Patrick, Culler, Michael D

“…Abstract Disclosure: G. Ravel: None. C. Chalmey: None. C. Berardet: None. D. Duracher: None. H. Kurasaki: None. T. Tomiyama: None. P. Reid: None. M.D. Culler:…”
Get full text

7145 Enhanced Ability of the Small Peptide GH Receptor Antagonist, AZP-3813, to Decrease IGF1 When Combined with the Somatostatin Analog, Octreotide by Ravel, Guillaume, Berardet, Corentin, Chalmey, Clémentine, Kurasaki, Haruaki, Tomiyama, Tatsuya, Reid, Patrick, Duracher, David, Datta, Rakesh, Aouadi, Myriam, Culler, Michael D

“…Abstract Disclosure: G. Ravel: None. C. Berardet: Employee; Self; Amolyt Pharma. C. Chalmey: Employee; Self; Amolyt Pharma. H. Kurasaki: Employee; Self;…”
Get full text